ArticleHealth technology assessment (Winchester, England)2026
Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm study.
Andrew Bryant et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.